Antipsychotic drug treatment plays a central role in the care of patients w
ith schizophrenia. The chronic nature of the illness means that most patien
ts are likely to require long-term antipsychotic medication to alleviate sy
mptoms and to prevent recurrence of an acute psychotic episode. Unfortunate
ly, a high proportion of patients with schizophrenia do not comply with med
ication and this has profound consequences in terms of the number and sever
ity of relapse episodes, rehospitalization rates, worsening of residual sym
ptoms and social costs, including substance misuse, homelessness and the bu
rden on carers. Ensuring that antipsychotic treatment is acceptable to the
patient is fundamental to managing adherence. Side-effects, particularly me
ntal and extrapyramidal symptoms (EPS), are the cause of much distress to p
atients and dissatisfaction with treatment, so a treatment regimen with a l
ow side effect profile will help to improve adherence to the treatment. Suc
h regimens have unmasked many of the other side-effects of treatment that w
ere previously viewed as subsidiary to EPS; but the physical and psychologi
cal consequences of side-effects suck as antipsychotic-induced sexual dysfu
nction or weight gain are highly distressing to the patient, and as likely
as EPS to trigger non-adherence to medication Consequently, careful selecti
on of antipsychotic agent and nose regimens is essential to maximize the ef
ficacy of the antipsychotic and to minimize the overall burden of side-effe
cts. Satisfaction also depends very much on the extent to which the patient
understands the treatment and its side-effects. Therefore, a close therape
utic alliance between the patient and the psychiatrist must underpin all at
tempts to increase the acceptability of treatment. This will allow the clin
ician to determine how the illness and its treatment are affecting all aspe
cts of the life of the patient, and then to tailor the treatment continuous
ly to obtain the best possible outcome for the patient.